Furthermore, the number of BCAS1-positive oligodendrocytes was reduced in inactive MS lesions in LOMS, and almost half of the lesions showed morphological changes suggesting impaired remyelination, with one-fifth of patients showing no BCAS1-positive cells at all. Here, BCAS1 is linked to myeloid sarcoma.